Association of in-hospital intensive statins dosage and death in arteriosclerotic cardiovascular disease with percutaneous coronary intervention: insights of multicentre cohort from China
ConclusionsThe in-hospital high-dose intensive statins are not associated with the lower risk of in-hospital or 30-day all-cause death among ASCVD patients undergoing PCI. Given the robust beneficial effect of high-dose intensive statins with in-hospital dialysis, an individualized high-dose intensive statin therapy can be rational in specified populations.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Angioplasty | Atorvastatin Calcium | Cardiology | Cardiovascular | China Health | Cholesterol | Coronary Angioplasty | Crestor | Dialysis | Drugs & Pharmacology | Heart | Lipitor | Percutaneous Coronary Intervention | Rosuvastatin | Statin Therapy | Study | Zivast